{"SPADE_UN_21622": {"Sequence Information": {"Peptide Name": "HB25, FLAKO3 AMD", "Sequence": "FALALKALKKLLKKLKKLAKKAL", "Sequence Length": 23, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Antimicrobial peptide therapeutics for cystic fibrosis.", "Pubmed ID": "15980369", "Reference": "Antimicrob Agents Chemother. 2005;49:2921-2927", "Author": "Zhang L, Parente J, Harris SM, Woods DE, Hancock RE, Falla TJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/15980369"}, {"Title": "Short bioactive peptides", "Pubmed ID": "", "Reference": "PATENT US 6875744B2. 2005;:", "Author": "Owen DR, Kenner LA", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/"}], "Mass": 2579.39, "PI": 10.9, "Net Charge": 9, "Hydrophobicity": 0.31, "Frequent Amino Acids": "KLA", "Absent Amino Acids": "CDEGHIMNOPQRSTUVWY", "Basic Residues": 9, "Acidic Residues": 0, "Hydrophobic Residues": 14, "Polar Residues": 9, "Positive Residues": 9, "Negative Residues": 0, "SPADE ID": "SPADE_UN_21622", "Similar Sequences": [{"SPADE_ID": "SPADE_N_06698", "Similarity": 1.0, "Sequence": "FALALKA"}, {"SPADE_ID": "SPADE_N_06699", "Similarity": 1.0, "Sequence": "FALALKAKKL"}, {"SPADE_ID": "SPADE_N_06700", "Similarity": 1.0, "Sequence": "FALALKALKK"}], "Hemolytic Activity": "Human fibroblasts WI-38:LD50=55 µg/ml,Human erythrocytes:50% Hemolysis=10 µg/ml", "Target Organism": "Escherichia coli UB1005(MIC=4µg/ml),Salmonella enterica serovar Typhimurium(MIC=8µg/ml),Pseudomonas aeruginosa PAO1(MIC=8µg/ml),Pseudomonas aeruginosa M76(MIC=32µg/ml),Pseudomonas aeruginosa M917(MIC=128µg/ml),Pseudomonas aeruginosa M1251(MIC=16µg/ml),Pseudomonas aeruginosa M1426(MIC=16µg/ml),Pseudomonas aeruginosa R70(MIC=16µg/ml),Staphylococcus aureus(MIC=8µg/ml),Candida albicans(MIC=64µg/ml),Pseudomonas stutzeri(MIC=2µg/ml),Pseudomonas fluorescens(MIC=8µg/ml),Ralstonia pickettii(MIC=4µg/ml),Stenotrophomonas maltophilia(MIC=4µg/ml),Achromobacter xylosoxidans(MIC=32µg/ml),Escherichia coli ATCC 25922(MBC=>80µg/ml),Pseudomonas aeruginosa ATCC 27853(MBC=30µg/ml),Staphylococcus aureus ATCC 25923(MBC=>40µg/ml),Candida albicans ATCC 10231(MFC=>50µg/ml),Human breast adenocarcinoma MCF-7(LD50=26µg/ml),Human colon adenocarcinoma SW480(LD50=38µg/ml),Human melanoma BMKC(LD50=85µg/ml),Human lung carcinoma H1299(LD50=72µg/ml),Human cervical carcinoma HeLa S3(LD50=145µg/ml),Human prostate adenocarcinoma PC-3(LD50=38µg/ml)"}}}